Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria.

Kozuma Y, Sawahata Y, Takei Y, Chiba S, Ninomiya H.

Br J Haematol. 2011 Mar;152(5):631-9. doi: 10.1111/j.1365-2141.2010.08505.x. Epub 2011 Jan 17.

PMID:
21241275
3.
4.

Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia.

Hugel B, Socié G, Vu T, Toti F, Gluckman E, Freyssinet JM, Scrobohaci ML.

Blood. 1999 May 15;93(10):3451-6.

5.

Complement inhibitor S protein is associated with membranes of red blood cells from patients with paroxysmal nocturnal haemoglobinuria.

Salama A, Preissner KT, Göttsche B, Müller-Berghaus G, Mueller-Eckhardt C.

Br J Haematol. 1988 Jan;68(1):41-5.

PMID:
3345295
6.
7.

Shortened lifespan of paroxysmal nocturnal haemoglobinuria-affected RBC estimated from differences in ratios of CD59-negative populations between reticulocytes and whole RBC.

Ninomiya H, Sato S, Hasegawa Y, Nagasawa T.

Int J Lab Hematol. 2008 Feb;30(1):41-5. doi: 10.1111/j.1365-2257.2007.00897.x.

PMID:
18190466
8.

Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH).

Shichishima T, Terasawa T, Uchida T, Kariyone S.

Br J Haematol. 1989 Aug;72(4):578-83.

PMID:
2775661
9.

Altered red cell and platelet adhesion in hemolytic diseases: Hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria and sickle cell disease.

Sakamoto TM, Canalli AA, Traina F, Franco-Penteado CF, Gambero S, Saad ST, Conran N, Costa FF.

Clin Biochem. 2013 Dec;46(18):1798-803. doi: 10.1016/j.clinbiochem.2013.09.011. Epub 2013 Sep 21.

PMID:
24060729
10.

Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia.

Lee M, Narayanan S, McGeer EG, McGeer PL.

PLoS One. 2014 Jan 29;9(1):e87316. doi: 10.1371/journal.pone.0087316. eCollection 2014.

11.

Increased sensitivity to complement of megakaryocyte progenitors in paroxysmal nocturnal haemoglobinuria.

Dessypris EN, Gleaton JH, Clark DA.

Br J Haematol. 1988 Jul;69(3):305-9.

PMID:
3408669
12.

Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.

Zhao L, Wu X, Si Y, Yao Z, Dong Z, Novakovic VA, Guo L, Tong D, Chen H, Bi Y, Kou J, Shi H, Tian Y, Hu S, Zhou J, Shi J.

J Neurosurg. 2016 Dec 23:1-14. doi: 10.3171/2016.8.JNS16996. [Epub ahead of print]

PMID:
28009236
13.

Activated platelets in paroxysmal nocturnal haemoglobinuria.

Gralnick HR, Vail M, McKeown LP, Merryman P, Wilson O, Chu I, Kimball J.

Br J Haematol. 1995 Nov;91(3):697-702.

PMID:
8555078
14.

Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.

Amer J, Zelig O, Fibach E.

Exp Hematol. 2008 Apr;36(4):369-77. doi: 10.1016/j.exphem.2007.12.003. Epub 2008 Feb 8.

PMID:
18261835
15.

Procoagulant role of microparticles in routine storage of packed red blood cells: potential risk for prothrombotic post-transfusion complications.

Aung HH, Tung JP, Dean MM, Flower RL, Pecheniuk NM.

Pathology. 2017 Jan;49(1):62-69. doi: 10.1016/j.pathol.2016.10.001. Epub 2016 Nov 26.

PMID:
27899173
16.

Microparticles in hemostasis and thrombosis.

Owens AP 3rd, Mackman N.

Circ Res. 2011 May 13;108(10):1284-97. doi: 10.1161/CIRCRESAHA.110.233056. Review.

17.

Correction of the PNH defect by GPI-anchored protein transfer.

Sloand EM, Maciejewski JP, Dunn D, Moss J, Brewer B, Kirby M, Young NS.

Blood. 1998 Dec 1;92(11):4439-45.

18.

Activation of complement by stroma from normal and paroxysmal nocturnal haemoglobinuria red cells.

De Sandre G, Corrocher R, Falezza GC, Aprili G, Caffi S.

Scand J Haematol. 1978 Mar;20(3):265-70.

PMID:
644255
19.

Procoagulant activity induced by transcatheter closure of atrial septal defects is associated with exposure of phosphatidylserine on microparticles, platelets and red blood cells.

Ding W, Kou J, Meng H, Kou Y, He Z, Cao M, Wang L, Bi Y, Thatte HS, Shi J.

Thromb Res. 2015 Aug;136(2):354-60. doi: 10.1016/j.thromres.2015.06.015. Epub 2015 Jun 12.

PMID:
26099643
20.

Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation.

Koshiar RL, Somajo S, Norström E, Dahlbäck B.

PLoS One. 2014 Aug 19;9(8):e104200. doi: 10.1371/journal.pone.0104200. eCollection 2014.

Supplemental Content

Support Center